Skip to main content
Clinical Trials/JPRN-UMIN000031972
JPRN-UMIN000031972
Completed
未知

Phase II study on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by placement of 4Fr prophylactic pancreatic duct stent in patients who is performed endoscopic pancreatic duct injection (multicenter study) - prevention of post-ERCP pancreatitis by placement of 4Fr prophylactic pancreatic duct stent

Wakayama Medical University0 sites250 target enrollmentStarted: March 29, 2018Last updated:

Overview

Phase
未知
Status
Completed
Enrollment
250

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • .acute pancreatitis .postoperative reconstructed intestinal tract (Billroth ii, Roux\-en\-Y method) .patient with serious systemic illness, dangerous condition of life .intraductal papillary mucinous neoplasm .complete obstruction of main pancreatic duct .patient who already registered in this study once

Investigators

Similar Trials

Recruiting
Phase 1
Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of biological therapy immediately after an ileocolonic resection with the start of biological therapy in patients with endoscopic recurrence six months after ileocolonic resectioPatients with Crohn's disease undergoing surgery and having at least one risk factor for postoperative recurrence of the disease.MedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
CTIS2022-500311-39-00Z Leuven352
Recruiting
Phase 1
Clinical study on the prevention of postoperative recurrence and metastasis of colorectal cancer by Zuojin pill combined with adjuvant chemotherapycolorectal cancer
ITMCTR2000003349Shuguang Hospital affillated with Shanghai University of TCM
Recruiting
Phase 4
Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological TherapyCrohn Disease
NCT05169593Universitaire Ziekenhuizen KU Leuven292
Completed
Not Applicable
The late follow-up endoscopy as bleeding prevention after the gastric endoscopic submucosal dissection in the patient with thienopyridine derivative or low-dose aspirin and warfarin combinatioGastric adenoma or early gastric cancer(cStage IA)
JPRN-UMIN000016475Japan Gastroenterological Endoscopy Society Hokuriku Chapter150
Not yet recruiting
Not Applicable
Prevention of Post-colon ESD Coagulation Syndrome using Polysaccharide Hemostatic PowderNeoplasms
KCT0008728Soon Chun Hyang University Hospital Cheonan196